According to Alexandria Real Estate Equities
's latest financial reports the company has $0.72 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.61 B | -25.09% |
2022-12-31 | $0.82 B | 128.37% |
2021-12-31 | $0.36 B | -36.44% |
2020-12-31 | $0.56 B | 199.73% |
2019-12-31 | $0.18 B | -19% |
2018-12-31 | $0.23 B | -7.94% |
2017-12-31 | $0.25 B | 103.45% |
2016-12-31 | $0.12 B | -0.05% |
2015-12-31 | $0.12 B | 45.44% |
2014-12-31 | $86.01 M | 49.08% |
2013-12-31 | $57.69 M | -59.07% |
2012-12-31 | $0.14 B | 79.49% |
2011-12-31 | $78.53 M | -13.91% |
2010-12-31 | $91.23 M | 29.17% |
2009-12-31 | $70.62 M | -0.75% |
2008-12-31 | $71.16 M | 786.19% |
2007-12-31 | $8.03 M | 172.39% |
2006-12-31 | $2.94 M | -24.62% |
2005-12-31 | $3.91 M | 23.84% |
2004-12-31 | $3.15 M | -36.65% |
2003-12-31 | $4.98 M | 31.53% |
2002-12-31 | $3.79 M | 59.51% |
2001-12-31 | $2.37 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $12.69 B | 1,657.19% | ๐บ๐ธ USA |
Eli Lilly LLY | $2.58 B | 258.13% | ๐บ๐ธ USA |
Amgen AMGN | $10.94 B | 1,415.42% | ๐บ๐ธ USA |
Gilead Sciences GILD | $7.26 B | 905.85% | ๐บ๐ธ USA |
Illumina ILMN | $1.05 B | 45.95% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $9.67 B | 1,239.01% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $2.37 B | 228.35% | ๐บ๐ธ USA |